2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$37.17-$0.19 (-0.51%)
Price as of Sep 11, 2026 7:30 PM EDT- $7.7BMarket Cap
- 131.19%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$37.17-$0.19 (-0.51%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $37.36 | ||
Change | -$0.74 (-1.94%) | ||
Open | $38.62 | ||
High | $38.93 | ||
Low | $37.19 | ||
Previous Close | $38.10 | ||
Volume | 1,031,890 | ||
30-Day Average Volume | 1,191,971 | ||
1-Week Change | -4.82% | ||
1-Month Change | -8.72% | ||
1-Year Change | 131.19% | ||
3-Year Change | 65.68% | ||
5-Year Change | 333.41% | ||
Fundamentals | |||
Shares Outstanding | 206.6M | ||
Total Assets | $852.5M | ||
Market Cap | $7.7B | ||
Enterprise Value | $6.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$153.2M | ||
Free Cash Flow | -$124.4M | ||
EBIT | -$153.2M | ||
EBITDA | -$153.1M | ||
Net Working Capital | $734.1M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -50 | ||
PEG | 14 | ||
Price/Free Cash Flow | -62 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue